Day: September 13, 2022

Alpha Star Acquisition Corporation Signs Letter of Intent for a Business Combination

Alpha Star Acquisition Corporation Signs Letter of Intent for a Business Combination

NEW YORK, Sept. 13, 2022 (GLOBE NEWSWIRE) — Alpha Star Acquisition Corporation (the “Company”) today announced that it has entered into a non-binding letter of intent (“LOI”) for a business combination with Cyclebit Group (the “Cyclebit”). Founded in 2012, Cyclebit is a global payments and SaaS provider. Its core products include card acquiring, point-of-sale (POS) services and marketplace solutions. Under the terms of the LOI, the Company and Cyclebit would become a combined entity, with the Cyclebit’s existing equityholders rolling 100% of their equity into the combined public company. The Company expects to announce additional details regarding the proposed business combination when a definitive agreement is executed, which is expected in the fourth quarter of 2022. No assurances can be made that the parties will successfully...

Continue reading

Sonoco Announces New Vice President of Global Mergers and Acquisitions

Sonoco Announces New Vice President of Global Mergers and Acquisitions

HARTSVILLE, S.C., Sept. 13, 2022 (GLOBE NEWSWIRE) — Sonoco (NYSE: SON), a diversified global packaging leader, today announced the appointment of Shawn Munday as the Vice President of Global Mergers and Acquisitions, reporting to Chief Financial Officer, Rob Dillard. Shawn will lead business development strategies, mergers and acquisitions (M&A), divestitures, and other strategic investment partnerships and activities on behalf of the Company. “Shawn is a dynamic and proven financial and corporate development leader with a successful track record of identifying investments and M&A opportunities for global organizations and we are delighted to have him join Sonoco,” said Rob Dillard, CFO. “He will provide thought leadership to our business unit leaders and executive team to identify, evaluate, and pursue growth and investment...

Continue reading

Iris Energy Reports Record Full Year FY22 Results

Iris Energy Reports Record Full Year FY22 Results

Key Highlights Record revenue of $59.0 million (+647% YoY) Record Adjusted EBITDA of $26.2 million (+1,791% YoY)1 Record Adjusted EBITDA Margin of 44% (+144% YoY)2 Record cash flow from operations of $21.6 million (+1,124% YoY) Record average operating hashrate of 747 PH/s (+611% YoY) and 1,398 Bitcoin mined (+422% YoY) from 100% renewable energy powered operations since inception3 $110.0 million cash and cash equivalents as of June 30, 2022 and no corporate debt4 Post financial year end: Agreement reached with Bitmain to ship an additional 1.7 EH/s of miners, increasing total expected Company operating capacity from 4.3 EH/s to 6.0 EH/s 1.5 EH/s (50MW) at Mackenzie (BC, Canada) energized ahead of schedule 1.4 EH/s (50MW) at Prince George (BC, Canada) on track for September 2022 Company operating capacity guidance increased from 4.3...

Continue reading

DAVIDsTEA Reports Financial Results for the Second Quarter of Fiscal 2022

DAVIDsTEA Reports Financial Results for the Second Quarter of Fiscal 2022

Sales totaled $15.2 million Net loss of $4.8 million Adjusted EBITDA amounted to a loss of $2.1 million Cash position of $19.0 million and new, unused $15.0 million revolving credit facility MONTREAL, Sept. 13, 2022 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (Nasdaq: DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North America, announced today its second quarter results for the period ended July 30, 2022. “DAVIDsTEA continues to experience volatility in its channels. Our wholesale business in Canada expanded in the second quarter of 2022 with sales more than doubling year-over-year on the strength of a growing footprint at grocery stores, pharmacies and big-box locations to over 3,800 doors, including a wider assortment of wellness-focused and organic products. We are launching a new sachet format that will be available...

Continue reading

Vintage Wine Estates Revenue Grew 32% to $75.5 Million in Fourth Quarter Fiscal 2022; Fiscal Year 2022 Revenue Increased to $293.8 Million

Vintage Wine Estates Revenue Grew 32% to $75.5 Million in Fourth Quarter Fiscal 2022; Fiscal Year 2022 Revenue Increased to $293.8 Million

Diversified business, omnichannel marketing and acquisitions drove revenue growth in all segments Fourth quarter business-to-business (“B2B”) sales grew 55% while strong tasting room traffic drove 10% organic growth in direct-to-consumer (“DTC”) Made significant progress to improve internal controls; implemented stringent processes around inventory management and financial processes that resulted in $19.1 million in non-cash inventory adjustments Fourth quarter net loss was $14.7 million reflecting non-cash inventory adjustments; adjusted net income improved to $10.0 million and adjusted EBITDA1 was $7.6 million Fiscal 22 revenue grew 33% to $293.8 million; net loss for the year was $(0.7) million, adjusted net income expanded to $25.2 million and adjusted EBTIDA1 was $46.8 million, up 21% over the prior year Continue...

Continue reading

Connect Biopharma Reports First Half 2022 Financial Results and Provides Business Update

Connect Biopharma Reports First Half 2022 Financial Results and Provides Business Update

– Company expects to report top-line data from China pivotal trial for lead drug candidate CBP-201 in atopic dermatitis in October 2022 – – Company to Host Conference Call Today at 4:30 p.m. ET – SAN DIEGO and TAICANG, China, Sept. 13, 2022 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global, clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases, today announced financial results for the six-month period ended June 30 and recent corporate highlights. “2022 has been a dynamic year for Connect Biopharma so far, with clinical progress in all three of our drug candidates, CBP-201, in atopic dermatitis (AD) (Global Phase 2b trial), CBP-307 (Phase 2), in ulcerative colitis (UC), and recently announced positive data for our...

Continue reading

InnovAge Announces Financial Results for the Fiscal Year and Fourth Quarter Ended June 30, 2022

InnovAge Announces Financial Results for the Fiscal Year and Fourth Quarter Ended June 30, 2022

DENVER, Sept. 13, 2022 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced financial results for its fiscal fourth quarter and full year ended June 30, 2022. “We ended the fiscal year with a census of approximately 6,650 participants and generated $698.6 million of revenue. Our results reflect the ongoing transformational journey at InnovAge and the core investments we are making in our business,” said Patrick Blair, President and Chief Executive Officer of InnovAge. “We have made measurable progress on our near-term operational improvements and strengthening our enterprise capabilities, and I am confident that we are on the right path to achieve our long-term aspirations for the Company.” Financial...

Continue reading

LAVA Therapeutics Provides Business Update and Reports Second Quarter Financial Results

LAVA Therapeutics Provides Business Update and Reports Second Quarter Financial Results

Initial Phase 1/2a clinical findings for LAVA-051 in patients with chronic lymphocytic leukemia and multiple myeloma patients demonstrated encouraging anti-tumor activity and safety profile; on track to report additional clinical data in fourth quarter 2022 Enrollment continuing in LAVA-1207 Phase 1/2a trial in metastatic castration-resistant prostate cancer Cash and investments of $110.7 million as of June 30, 2022, providing approximately two years of cash runway Appointed James Noble and Jay Backstrom, M.D., M.P.H., as non-executive directors to the Company’s board of directors UTRECHT, The Netherlands and PHILADELPHIA, Sept. 13, 2022 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific gamma delta T...

Continue reading

Frequency Electronics, Inc. Announces First Quarter Fiscal Year 2023 Financial Results

Frequency Electronics, Inc. Announces First Quarter Fiscal Year 2023 Financial Results

MITCHEL FIELD, N.Y., Sept. 13, 2022 (GLOBE NEWSWIRE) — Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM) is reporting revenues for the first quarter ended July 31, 2022, of approximately $8.2 million compared to revenues of $13.0 million for the first quarter of fiscal 2022, ended July 31, 2021. Operating loss for the first quarter of fiscal 2023 was $3.1 million compared to an operating loss of $1.7 million for the same period of fiscal 2022. Net loss from operations was $3.1 million or ($0.33) per diluted share compared to a net loss of $1.6 million or ($0.17) per diluted share for the first quarter of fiscal year 2022. FEI Interim President and CEO, Thomas McClelland commented, “The first quarter of fiscal 2023, continued to be challenging financially, but aggressive steps to correct things are in progress....

Continue reading

Aspen Group Reports Revenue of $18.9 million for First Quarter Fiscal 2023

Aspen Group Reports Revenue of $18.9 million for First Quarter Fiscal 2023

Marketing spend decrease in Q4 2022 resulted in modest revenue decline in Q1 2023 Restructuring and lower marketing spend expected to reduce total spending by $4.4 million in Q2 and $4.9 million per quarter in Q3 and Q4 of fiscal year 2023 Continued corporate overhead controls drive sequential reduction in G&A NEW YORK, Sept. 13, 2022 (GLOBE NEWSWIRE) — Aspen Group, Inc. (Nasdaq: ASPU) (“AGI”), an education technology holding company, today announced financial results for its first quarter fiscal year 2023 ended July 31, 2022. First Quarter Fiscal Year 2023 Summary Results   Three Months Ended July 31, $ in millions, except per share data   2022       2021   Revenue $ 18.9     $ 19.4   Gross Profit1 $ 8.2     $ 10.4   Gross Margin (%)1   43 %     54 % Net Income (Loss) $ (3.7 )   $ (0.9 ) Earnings (Loss) per...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.